CHRISTINE CORCORAN: Open Payments
NPI 1043253404 · PEEKSKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 92 payments from 8 companies in 2025. Trend: 2023 $632 · 2024 $1,151 · 2025 $1,183
Food & beverage: $1,183
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 34 | $424 |
| ABBVIE INC. | 29 | $358 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $280 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, TRINTELLIX, Auvelity, COBENFY, REXULTI, ARISTADA.
Industry payments across NY — which companies pay providers there.
